Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2019 Nov 4;61(3):614–622. doi: 10.1080/10428194.2019.1680839

Figure 1:

Figure 1:

Day +7 asparaginase (ASNase) activity of reduced dose induction pegylated asparaginase (RED PEG-ASP). Dashed line corresponds to an ASNase activity level of 0.1 IU/mL, indicating achievement of ‘guideline adherent’ dosing of PEG-ASP. 2/4 patients in the 250 IU/m2, 9/11 in the 500 IU/m2, and 11/11 in the 1000 IU/m2 groups achieved an ASNase activity level ≥0.1 IU/mL. The 1000 IU/m2 dose group achieved significantly higher ASNase levels compared to either group.